Vijay Kumar | Drug Discovery and Development | Editorial Board Member

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Vijay Kumar | Drug Discovery and Development | Editorial Board Member

Dr B R Ambedkar NIT Jalandhar, India

Assoc. Prof. Dr. Vijay Kumar is a distinguished researcher, academician, and innovator in the fields of artificial intelligence, machine learning, biomedical informatics, cybersecurity, image processing, and computational intelligence. Over the course of his career, he has established himself as a prolific contributor whose research bridges advanced computational theories with real-world applications, particularly in healthcare, pandemic intelligence, medical imaging, network security, and autonomous systems. His academic journey is defined by a commitment to solving high-impact global challenges through intelligent algorithms, deep learning frameworks, optimization strategies, and secure data-driven technologies.Dr. Vijay Kumar’s scholarly work reflects exceptional depth and diversity. He has authored impactful publications in leading journals such as IEEE Transactions on Vehicular Technology, IEEE Journal of Biomedical and Health Informatics, Vaccine, Artificial Intelligence Review, Archives of Computational Methods in Engineering, Multimedia Tools and Applications, Computers in Biology and Medicine, and Biomedical Signal Processing and Control. His research spans a broad spectrum—from deepfake detection, autonomous vehicle visibility enhancement, multi-objective optimization, and cybersecurity frameworks, to intelligent diagnostic models for COVID-19, breast cancer, cervical cancer, and other critical diseases. His studies on advanced metaheuristic algorithms, chaotic encryption systems, drug synergy prediction, air-quality forecasting, and big healthcare data security have contributed significantly to modern computational science. A visionary in interdisciplinary AI, Dr. Kumar has collaborated extensively with international researchers, producing high-impact work on deep neural networks, generative adversarial models, hybrid optimization techniques, multimodal medical imaging, and cloud-based encryption systems. His contributions to pandemic preparedness, especially ML-driven vaccine development roadmaps and intelligent screening systems, highlight his dedication to translating technology into meaningful societal outcomes.He is also recognized for designing innovative algorithms such as lightweight NIDS architectures, evolutionary visibility restoration models, customized dehazing networks, and novel feature-selection optimizers. His body of work has become a reference point for emerging scholars in computer science, health informatics, and computational engineering.Dr. Vijay Kumar continues to lead transformative research, mentor young scientists, and contribute to global scientific advancement through his extensive publication record, collaborative projects, and commitment to innovation. His enduring academic excellence and forward-looking approach place him among the most influential researchers driving the future of intelligent systems and healthcare-focused artificial intelligence.

Profile: Google Scholar

Featured Publications

Katoch, S., Chauhan, S. S., & Kumar, V. (2020). A Review on Genetic Algorithm: Past, Present, and Future. Multimedia Tools and Applications, 52, 5252.

Dhiman, G., & Kumar, V. (2019). Seagull optimization algorithm: Theory and its applications for large‑scale industrial engineering problems. Knowledge‑Based Systems, 165, 169‑196.

Dhiman, G., & Kumar, V. (2017). Spotted Hyena Optimizer: A Novel Bio‑inspired based Metaheuristic Technique for Engineering Applications. Advances in Engineering Software, 114, 48‑70.

Dhiman, G., & Kumar, V. (2018). Emperor Penguin Optimizer: A Bio‑inspired Algorithm for Engineering Problems. Knowledge‑Based Systems, 159, 20‑50.

Singh, D., Kumar, V., Vaishali, & Kaur, M. (2020). Classification of COVID‑19 patients from chest CT images using multi‑objective differential evolution–based convolutional neural networks. European Journal of Clinical Microbiology & Infectious Diseases, 39, 1379‑1389.

Jaiswal, A., Gianchandani, N., Singh, D., Kumar, V., & Kaur, M. (2020). Classification of the COVID‑19 infected patients using DenseNet201 based deep transfer learning. Journal of Biomolecular Structure and Dynamics, 73, 1‑?.

Dhiman, G., Garg, M., Nagar, A., Kumar, V., & Dehghani, M. (2020). A Novel Algorithm for Global Optimization: Rat Swarm Optimizer. Journal of Ambient Intelligence and Humanized Computing, 5, 12‑?.

Das, N. N., Kumar, N., Kaur, M., Kumar, V., & Singh, D. (2020). Automated deep transfer learning‑based approach for detection of COVID‑19 infection in chest X‑rays. IRBM, 4, 25‑?.

Kaur, M., & Kumar, V. (2020). A comprehensive review on image encryption techniques. Archives of Computational Methods in Engineering, 27(1), 390.

Song Guo Zheng | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Song Guo Zheng | Drug Discovery and Development | Best Researcher Award

Chair Professor at Shanghai Jiao Tong University School of Medicine | China

Prof. Song Guo Zheng, M.D., Ph.D., is an internationally renowned immunologist and clinician-scientist specializing in rheumatology, molecular immunology, and translational medicine. He currently serves as Chair Professor and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University. With academic leadership roles across prestigious institutions in the U.S. and China, his pioneering work spans autoimmunity, cell therapy, and immunoregulation. A prolific author with over 110 peer-reviewed publications in top-tier journals, Prof. Zheng is also a highly decorated researcher and active leader in global immunology societies. His contributions continue to shape modern immunotherapy and precision medicine.

Publication Profile 

Google Scholar

Orcid

Education 

Prof. Zheng earned his Ph.D. in Molecular Immunology from the University of Orleans, France (2011), and a Master’s in Pathology and Immunology from Shanghai Medical University (1992). He completed his M.D. at Anhui Medical University (1984). His clinical training included a residency in surgery at Chizhou City Hospital (1984–1989) and an internship at Shanghai Zhabei Hospital (1983–1984). He further pursued a pathology fellowship at Shanghai Medical University Cancer Hospital (1989–1993). These academic and clinical foundations laid the groundwork for a distinguished career in immunology, clinical research, and translational medicine across both China and the United States.

Experience 

Prof. Zheng currently serves as Chair Professor at Shanghai Jiao Tong University and Dean of the School of Cell and Gene Therapy (2023–Present). He previously held senior positions including the Ronald L. Whisler Chair in Rheumatology and Immunology at Ohio State University (2018–2022) and Director at Penn State University’s College of Medicine (2013–2018). His U.S. academic journey began at the University of Southern California as an assistant and associate professor (2004–2013), after postdoctoral work at USC and UCLA. With leadership in research, teaching, and clinical science, he has become a global authority in immunological therapeutics and rheumatology.

Awards

Prof. Zheng has received numerous prestigious honors, including the Outstanding Scientist Award (2023, USA) and the Distinguished Clinical Immunologist Award (2019, China). He was awarded the Edmund L. Dubois Award (2019), NIH STAR Award (2016–2021), and was Chair of NIH MOSS Study Section (2016). Notably, he earned the James R. Klinenberg Award for best immunologist in Southern California (2007) and the Freda Newton Memorial Scholar Award (2006). He is an elected member of The Henry Kunkel Society (2012) and a recipient of the ACR Investigator Award (2008–2010), reflecting his impactful and sustained contributions to clinical immunology.

Research Focus 

Prof. Zheng’s research centers on molecular immunology, particularly in autoimmune diseases, Treg/Th17 cell modulation, and immune tolerance mechanisms. He investigates immunometabolism, gene and cell therapy, and inflammatory signaling pathways with an emphasis on clinical translation. His studies on cytokines, nanomedicine, and immune checkpoint regulation aim to advance precision therapeutics for rheumatic and inflammatory diseases. He integrates cutting-edge techniques including single-cell sequencing, CRISPR-based modulation, and nano-drug delivery systems. His innovative research is highly cited and supports next-generation treatments for autoimmunity, cancer immunotherapy, and organ-specific inflammation, shaping global trends in immune-based medical interventions.

Publication Top Notes

Natural and induced CD4+ CD25+ cells educate CD4+ CD25− cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10

IL-2 is essential for TGF-β to convert naive CD4+ CD25− cells to CD25+ Foxp3+ regulatory T cells and for expansion of these cells

Role of vitamin A in the immune system

Generation ex vivo of TGF-β-producing regulatory T cells from CD4+ CD25− precursors

Vitamin D and chronic diseases

TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells

Natural and TGF-β–induced Foxp3+ CD4+ CD25+ regulatory T cells are not mirror images of each other

Role of TNF–TNF receptor 2 signal in regulatory T cells and its therapeutic implications

Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6

Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets

Conclusion

Given his outstanding scientific productivity, leadership in global immunology communities, and groundbreaking research on immune regulation, Prof. Song Guo Zheng is highly suitable for the Best Researcher Award. His body of work demonstrates not only scientific depth and innovation but also sustained impact on the field of immunology and clinical medicine. With ongoing contributions and strategic improvements, he remains a central figure in advancing immune-based therapies and education worldwide.

Prof Dr.Christophe LEN| Pharmaceutical Chemistry|Excellence in Research

Published on by Top Pharmaceutical

Prof Dr.Christophe LEN,Pharmaceutical Chemistry ,Excellence in Research

Prof Dr.Christophe LEN, at Chimie ParisTech, France

 Profiles

Scopus

Orcid

🎓Early Academic Pursuits

Professor Dr. Christophe Len’s academic journey began at Université de Picardie Jules Verne in Amiens, France, where he completed his Master of Science (MsC) in Chemistry in 1992. His pursuit of advanced knowledge continued as he earned his PhD in Chemistry from the same institution in 1995. Following his doctoral studies, Dr. Len undertook a post-doctoral fellowship at the University of Hull in England from 1996 to 1997. This period was crucial in shaping his research trajectory and establishing a solid foundation in organic chemistry and catalysis.

🏢Professional Endeavors

Dr. Len’s career is marked by a series of esteemed positions across prominent institutions. He began his academic career as an Assistant Professor at Université de Picardie Jules Verne in 1997. His exceptional contributions led to his rapid ascension in the academic hierarchy, securing a Full Professor position at Université de Poitiers in 2004. Subsequently, he moved to Université de Technologie de Compiègne, where he has served in various capacities, including Full Professor (second class) in 2008 and Full Professor (first class) in 2011. His current role as a Full Professor (Exceptional class) at Chimie ParisTech and Université de Technologie de Compiègne reflects his significant impact and leadership in the field.

🔬Contributions and Research Focus

Dr. Len’s research primarily revolves around innovative approaches in organic chemistry and catalysis. He is renowned for his work in continuous flow chemistry, which enhances the efficiency and sustainability of chemical processes. His expertise extends to applying cutting-edge technologies such as microwave, ultrasound, and ball milling to catalysis, both homogeneous and heterogeneous. His pioneering research on micellar catalysis has further advanced the field, demonstrating his commitment to exploring and developing new methodologies in chemistry.

🏆Accolades and Recognition

Professor Len’s outstanding contributions have earned him numerous accolades and recognition. In 2017, he was honored with the Glycerine Innovation Research Award by the American Oils Chemists’ Society (AOCS). His scholarly excellence has been recognized through various honorary appointments, including Honorary Professor at the University of Hull (2012-2018) and Honorary Professor at Xi’an Jiaotong University, China (2022-2025). He is also a Fellow of the Royal Society of Chemistry (FRSC) and holds honorary life fellowships with the Association of Carbohydrate Chemists and Technologists India (ACCTI) and the Indian Society of Chemists and Biologists (ISCB).

Dr. Len’s editorial roles reflect his influence in the field: he is a member of the editorial boards for several prestigious journals, including Sustainability (Sust. Chem. Eng. Technol.), Material Chemistry (Materials), Biomass Catalysis (Catalysts), and Green Chemistry (Molecules). His service on the management committee for the COST Action FP1306 and the CNRS GDR2053 Synth-Flux further underscores his leadership in advancing green chemistry and flow synthesis technologies.

🌟Impact and Influence

With an impressive h-index of 49 (Scopus) and 51 (Google Scholar), Dr. Len’s work has had a profound impact on the field of chemistry. His research, which includes over 250 peer-reviewed journal articles, 11 patents, and 13 book chapters, has garnered significant attention and citation, reflecting the relevance and quality of his contributions. His extensive participation in conferences and oral communications, as well as his prolific output in posters, showcases his active engagement with the scientific community and his role in disseminating knowledge.

🌍Legacy and Future Contributions

Dr. Len’s legacy is marked by his transformative contributions to organic chemistry and catalysis. His innovative approaches and dedication to advancing chemical processes have set new standards in the field. Looking ahead, his ongoing work in continuous flow chemistry and green chemistry continues to shape the future of sustainable chemical practices. His involvement in global research clusters and editorial boards highlights his commitment to fostering collaboration and driving progress in chemistry.

Professor Dr. Christophe Len’s career exemplifies excellence and innovation in the scientific community. His contributions not only advance fundamental chemistry but also pave the way for future research and applications, solidifying his position as a leading figure in his field.

🎓Publication 

Photocatalytic oxidative desulfurization with Anderson-type polyoxometalates nanoclusters doped carbon nitride

  • Authors   :Zhao, D., Liu, Q., Lü, H., Zhao, J., Len, C.
  • Journal    :Colloids and Surfaces A: Physicochemical and Engineering Aspects
  • Year         : 2024

Glycerol: A green solvent for synthetic chemistry

    • Authors : de Nazaré de Oliveira, A., Melchiorre, M., Farias da Costa, A.A., Santos do Nascimento, L.A., Len, C.
    • Journal   :Sustainable Chemistry and Pharmacy
    • Year       : 2024
Robust synergistic effect between Zn1Mo1 bifunctional TiO2 for efficient ethyl levulinate production from furfural alcohol
  • Authors  :Si, Q., Zhao, D., Yang, Z., Zhao, J., Zhang, H.
  • Journal    :Materials Today Chemistry
  • Year         :  2024
Anderson-type polyoxometalates support on orange peel activated carbon for efficient ethyl levulinate production
  • Authors  : Zhao, D., Zhang, S., Si, Q., Xu, Y., Zhang, H.
  • Journal   :Fuel
  • Year        :   2024

Green and efficient deep eutectic solvent mediated one-step synthesis of Suxamethonium Chloride as Active Pharmaceutical Ingredient

  • Authors  : Sagandira, C.R., Nguyen, R., Liu, Q., Len, C.
  • Journal   :Sustainable Chemistry and Pharmacy
  • Year        : 2024